MQS Management LLC acquired a new position in shares of AMERISAFE, Inc. (NASDAQ:AMSF - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 5,631 shares of the insurance provider's stock, valued at approximately $296,000.
A number of other hedge funds have also recently bought and sold shares of AMSF. Royce & Associates LP purchased a new position in shares of AMERISAFE in the 4th quarter worth about $15,738,000. Raymond James Financial Inc. purchased a new position in shares of AMERISAFE in the 4th quarter worth about $9,708,000. Geode Capital Management LLC boosted its holdings in shares of AMERISAFE by 18.4% in the 4th quarter. Geode Capital Management LLC now owns 536,836 shares of the insurance provider's stock worth $27,675,000 after buying an additional 83,297 shares during the last quarter. GAMMA Investing LLC boosted its holdings in shares of AMERISAFE by 6,160.6% in the 1st quarter. GAMMA Investing LLC now owns 84,080 shares of the insurance provider's stock worth $4,418,000 after buying an additional 82,737 shares during the last quarter. Finally, Nuveen Asset Management LLC boosted its holdings in shares of AMERISAFE by 92.1% in the 4th quarter. Nuveen Asset Management LLC now owns 161,815 shares of the insurance provider's stock worth $8,340,000 after buying an additional 77,582 shares during the last quarter. 97.41% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Separately, JMP Securities reaffirmed a "market outperform" rating and set a $65.00 price objective on shares of AMERISAFE in a report on Wednesday, April 30th.
View Our Latest Stock Report on AMERISAFE
AMERISAFE Stock Performance
NASDAQ AMSF traded down $0.45 during trading on Friday, hitting $45.20. 45,825 shares of the company's stock traded hands, compared to its average volume of 108,506. The stock has a market capitalization of $861.06 million, a price-to-earnings ratio of 18.23 and a beta of 0.40. AMERISAFE, Inc. has a 12-month low of $42.48 and a 12-month high of $60.24. The business has a 50 day moving average of $45.30 and a 200-day moving average of $48.47.
AMERISAFE (NASDAQ:AMSF - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The insurance provider reported $0.60 earnings per share for the quarter, topping the consensus estimate of $0.59 by $0.01. AMERISAFE had a net margin of 15.76% and a return on equity of 16.41%. The company had revenue of $83.78 million for the quarter, compared to analysts' expectations of $76.66 million. On average, analysts expect that AMERISAFE, Inc. will post 2.45 EPS for the current year.
AMERISAFE Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, June 20th. Investors of record on Friday, June 13th were paid a $0.39 dividend. This represents a $1.56 dividend on an annualized basis and a yield of 3.45%. The ex-dividend date of this dividend was Friday, June 13th. AMERISAFE's payout ratio is 62.90%.
AMERISAFE Company Profile
(
Free Report)
AMERISAFE, Inc, an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.
Read More

Before you consider AMERISAFE, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMERISAFE wasn't on the list.
While AMERISAFE currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.